Stein Gold, Linda, Kilian Eyerich, Howard Sofen, Pedro Herranz, Leon Kircik, Tony Bewley, Eric Wolf, Gaia Gallo, Yuxin Ding, Fan Emily Yang, Ignasi Pau-Charles, and Melinda Gooderham. “Lebrikizumab Demonstrates Consistent Efficacy at 16 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis Regardless of Baseline Disease Severity”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s274. Accessed July 3, 2024. https://jofskin.org/33014/index.php/skin/article/view/2385.